uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Egrifta
Application withdrawn
Human
Details
EMA number
EMEA/H/C/002427
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of excess abdominal fat in HIV-infected patients with lipodystrophy
Active substances
tesamorelin
Marketing Authorisation Holder
Ferrer Internacional S.A.
MAH
Egrifta | uMedical